Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vasomotor Symptoms Associated With Menopause”

47 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 47 results

Large-scale testing (Phase 3)Study completedNCT01101841
What this trial is testing

24-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms

Who this might be right for
Hot Flashes
Noven Therapeutics 570
Testing effectiveness (Phase 2)Study completedNCT02834312
What this trial is testing

E4Relief (Response to Estetrol in Life Improvement for MEnopausal-associated Hot Flushes)

Who this might be right for
Hot Flushes
Donesta Bioscience 260
Not applicableActive Not RecruitingNCT07455812
What this trial is testing

A Study in Germany to Learn About the Value of Fezolinetant in Treating Hot Flashes and Night Sweats in Women During Menopause

Who this might be right for
Hot Flashes
Astellas Pharma Europe Ltd. 105
Large-scale testing (Phase 3)Study completedNCT00234819
What this trial is testing

Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Symptoms Associated With Menopause

Who this might be right for
Vasomotor Symptoms Associated With Menopause
Wyeth is now a wholly owned subsidiary of Pfizer 325
Testing effectiveness (Phase 2)Study completedNCT03596762
What this trial is testing

BAY3427080 (NT-814) in the Treatment of Moderate to Severe Post-menopausal Vasomotor Symptoms

Who this might be right for
MenopauseHot FlashesNight Waking
Bayer 199
Large-scale testing (Phase 3)Study completedNCT00535288
What this trial is testing

Dose-Finding Safety and Efficacy Trial of Org 50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (177001/P06472/MK-8265-013)

Who this might be right for
Postmenopausal SymptomsMenopauseVasomotor Symptoms
Merck Sharp & Dohme LLC 946
Large-scale testing (Phase 3)Study completedNCT00683800
What this trial is testing

Study Evaluating The Safety And Efficacy Of Desvenlafaxine Succinate For Vasomotor Symptoms In Menopausal Women

Who this might be right for
Vasomotor Symptoms
Pfizer 2,186
Testing effectiveness (Phase 2)Study completedNCT00786188
What this trial is testing

Eight-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms Associated With Menopause

Who this might be right for
Hot Flashes
Noven Therapeutics 102
Large-scale testing (Phase 3)Study completedNCT00560833
What this trial is testing

Dose-Finding Safety and Efficacy Trial of Org50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (46101/P06459/MK-8265-012)

Who this might be right for
MenopauseVasomotor Symptoms
Merck Sharp & Dohme LLC 943
Not applicableLooking for participantsNCT07602530
What this trial is testing

A Study in Canada to Follow Outcomes of Women in Menopause Treated With Fezolinetant for Hot Flashes, When Given in Clinical Practice

Who this might be right for
Hot Flashes
Astellas Pharma Europe Ltd. 238
Not applicableStudy completedNCT07408115
What this trial is testing

Herbal Dietary Supplementation on Vasomotor Symptoms in Menopausal Women

Who this might be right for
Hot FlashesHot FlashHot Flushes, Menopause, Postmenopause+6 more
Bonafide Health 112
Not applicableEnrolling By InvitationNCT07511660
What this trial is testing

Intra Ovarian Muse Cell Injection for Perimenopause Symptom Relief and Ovarian Function Restoration (MUSE-OVARY)

Who this might be right for
PerimenopausePerimenopause-Related DepressionPremature Ovarian Insufficiency+19 more
Healing Hope International 12
Testing effectiveness (Phase 2)Study completedNCT05034042
What this trial is testing

Find the Best Dose of Fezolinetant to Treat Hot Flashes in Women Going Through Menopause

Who this might be right for
Hot Flashes
Astellas Pharma Inc 147
Testing effectiveness (Phase 2)Study completedNCT00314964
What this trial is testing

Study Evaluating PD-0299685 for the Treatment of Vasomotor Symptoms (Hot Flashes / Flushes) Associated With Menopause

Who this might be right for
Hot Flashes
Pfizer 527
Large-scale testing (Phase 3)Study completedNCT05030584
What this trial is testing

Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 52 Weeks in Women Who Have Been Through the Menopause

Who this might be right for
Vasomotor Symptoms Associated With MenopauseHot Flashes
Bayer 628
Large-scale testing (Phase 3)Study completedNCT06206408
What this trial is testing

Confirm if Fezolinetant Helps Reduce Hot Flashes in Japanese Women Going Through Menopause

Who this might be right for
Hot Flashes
Astellas Pharma Inc 410
Not applicableEnded earlyNCT01353963
What this trial is testing

Desvenlafaxine Succinate (Pristiq): Postmarketing Surveillance Study Among Filipino Patients

Who this might be right for
Major Depressive DisorderVasomotor Symptoms
Pfizer 13
Post-approval studies (Phase 4)UnknownNCT01116310
What this trial is testing

Clinical Trial to Evaluate the Efficacy of FITOGYN Versus Placebo on the Vasomotor Symptomatology Associated With Menopause

Who this might be right for
Postmenopausal Women With Moderate Vasomotor Symptoms
Laboratorios Casen-Fleet S.L.U. 166
Large-scale testing (Phase 3)Study completedNCT05042362
What this trial is testing

Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 26 Weeks in Women Who Have Been Through the Menopause

Who this might be right for
Vasomotor Symptoms Associated With MenopauseHot Flashes
Bayer 396
Post-approval studies (Phase 4)Study completedNCT00160173
What this trial is testing

Efficacy Study Comparing 0.9 g and 1.25 g Estrogel With Placebo for Vasomotor Symptoms and Vulvar and Vaginal Atrophy

Who this might be right for
Postmenopausal Symptoms
ASCEND Therapeutics 221
Load More Results